Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers and infarct size.

R M Norris

    Journal of Molecular and Cellular Cardiology
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Beta blockers reduce myocardial oxygen demand, benefiting patients with severe myocardial ischemia. Early intravenous beta blocker use in myocardial infarction reduces infarct size and mortality, saving lives.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anatomy of the nasal profile.

    Journal of anatomy·2009
    Same author

    Circumstances of out of hospital cardiac arrest in patients with ischaemic heart disease.

    Heart (British Cardiac Society)·2005
    Same author

    Can successful treatment of cardiac arrest be a performance indicator for hospitals?

    Resuscitation·2004
    Same author

    Myocardial infarction: is evidence-based medicine the best?

    Lancet (London, England)·2002
    Same author

    Early days in the Coronary Care Unit.

    The New Zealand medical journal·2001
    Same author

    Redefinition of myocardial infarction.

    Lancet (London, England)·2001
    Same journal

    Sex- and stressor-dependent effects of metformin on cardiac fibrosis in plasminogen activator inhibitor-1 deficiency.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.

    Journal of molecular and cellular cardiology·2026
    Same journal

    SnRNA-seq identifies FN1-SDC4 axis triggering epicardial activation in right ventricular remodeling in pulmonary hypertension.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Therapeutic impact of normal dietary patterns on diabetic cardiomyopathy: Transcriptomic and proteomic insights.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathy.

    Journal of molecular and cellular cardiology·2026
    Same journal

    Precision modification of heart failure signaling by CRISPR-Cas9 base editing.

    Journal of molecular and cellular cardiology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Severe myocardial ischemia leads to infarction due to oxygen supply-demand imbalance.
    • Rate-pressure product is a key determinant of infarct size and is reduced by beta blockers.

    Purpose of the Study:

    • To evaluate the benefits of beta blockers in managing myocardial ischemia and infarction.
    • To assess the impact of beta blockers on infarct size, cardiac metabolism, and mortality.

    Main Methods:

    • Review of experimental and clinical studies on beta blocker efficacy in myocardial ischemia.
    • Analysis of data on rate-pressure product, cardiac metabolism, infarct size indices, and mortality rates.

    Main Results:

    • Intravenous beta blockers reduced rate-pressure product by ~20% and improved cardiac metabolism in patients with infarction.

    Related Experiment Videos

  • Beta blockers reduced indirect infarct size markers (serum enzymes, R wave loss) and ventricular fibrillation in animal models.
  • Large trials show a ~15% reduction in mortality with intravenous beta blockers, suggesting significant clinical benefit.

    • Conclusions:

    • Beta blockers are beneficial in severe myocardial ischemia by reducing oxygen demand and infarct size.
    • Routine intravenous beta blocker administration in myocardial infarction reduces mortality and saves lives.